ACET Adicet Bio Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ACET

Price (delayed)

$2.02

Market cap

$165.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.31

Enterprise value

$27.16M

Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of 'off-the-shelf' gamma delta ...

Highlights
Adicet Bio's debt has decreased by 4% QoQ
The company's net income has shrunk by 104% YoY
The gross profit has dropped by 100% year-on-year
Sector: Healthcare
Industry: Biotechnology
Website: http://www.adicetbio.com
Peers: KWR PFE MRK TEVA

Key stats

What are the main financial stats of ACET
Market
Shares outstanding
82.15M
Market cap
$165.95M
Enterprise value
$27.16M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.51
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$142.63M
EBITDA
-$133.69M
Free cash flow
-$98.18M
Per share
EPS
-$3.31
Free cash flow per share
-$2.28
Book value per share
$3.94
Revenue per share
$0
TBVPS
$4.82
Balance sheet
Total assets
$207.3M
Total liabilities
$37.12M
Debt
$20.92M
Equity
$170.18M
Working capital
$142.99M
Liquidity
Debt to equity
0.12
Current ratio
8.41
Quick ratio
8.28
Net debt/EBITDA
1.04
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-55.8%
Return on equity
-65.6%
Return on invested capital
-262.9%
Return on capital employed
-75.9%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ACET stock price

How has the Adicet Bio stock price performed over time
Intraday
-11.01%
1 week
-9.82%
1 month
3.59%
1 year
-66.22%
YTD
6.88%
QTD
-14.04%

Financial performance

How have Adicet Bio's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$152.04M
Net income
-$142.66M
Gross margin
N/A
Net margin
N/A
ACET's operating income has plunged by 110% YoY
The company's net income has shrunk by 104% YoY
The gross profit has dropped by 100% year-on-year
Adicet Bio's revenue has shrunk by 100% YoY

Growth

What is Adicet Bio's growth rate over time

Valuation

What is Adicet Bio stock price valuation
P/E
N/A
P/B
0.51
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
ACET's EPS has dropped by 95% year-on-year
ACET's price to book (P/B) is 61% lower than its 5-year quarterly average of 1.5 but 16% higher than its last 4 quarters average of 0.5
Adicet Bio's equity has decreased by 42% YoY and by 13% QoQ
Adicet Bio's revenue has shrunk by 100% YoY

Efficiency

How efficient is Adicet Bio business performance
ACET's ROE has shrunk by 185% YoY and by 14% QoQ
Adicet Bio's return on assets has shrunk by 171% YoY and by 12% QoQ
Adicet Bio's ROIC has plunged by 108% YoY and by 2.4% from the previous quarter

Dividends

What is ACET's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ACET.

Financial health

How did Adicet Bio financials performed over time
The quick ratio has decreased by 37% YoY and by 11% from the previous quarter
ACET's current ratio is down by 37% year-on-year and by 11% since the previous quarter
Adicet Bio's debt is 88% lower than its equity
ACET's debt to equity has soared by 71% YoY and by 9% QoQ
Adicet Bio's equity has decreased by 42% YoY and by 13% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.